Alanine dosimetry in strong magnetic fields: use as a transfer standard in MRI-guided radiotherapy. by Billas, I et al.
Physics in Medicine & Biology
     
ACCEPTED MANUSCRIPT • OPEN ACCESS
Alanine dosimetry in strong magnetic fields: use as a transfer standard in
MRI-guided radiotherapy
To cite this article before publication: Ilias Billas et al 2020 Phys. Med. Biol. in press https://doi.org/10.1088/1361-6560/ab8148
Manuscript version: Accepted Manuscript
Accepted Manuscript is “the version of the article accepted for publication including all changes made as a result of the peer review process,
and which may also include the addition to the article by IOP Publishing of a header, an article ID, a cover sheet and/or an ‘Accepted
Manuscript’ watermark, but excluding any other editing, typesetting or other changes made by IOP Publishing and/or its licensors”
This Accepted Manuscript is © 2020 Institute of Physics and Engineering in Medicine.
 
As the Version of Record of this article is going to be / has been published on a gold open access basis under a CC BY 3.0 licence, this Accepted
Manuscript is available for reuse under a CC BY 3.0 licence immediately.
Everyone is permitted to use all or part of the original content in this article, provided that they adhere to all the terms of the licence
https://creativecommons.org/licences/by/3.0
Although reasonable endeavours have been taken to obtain all necessary permissions from third parties to include their copyrighted content
within this article, their full citation and copyright line may not be present in this Accepted Manuscript version. Before using any content from this
article, please refer to the Version of Record on IOPscience once published for full citation and copyright details, as permissions may be required.
All third party content is fully copyright protected and is not published on a gold open access basis under a CC BY licence, unless that is
specifically stated in the figure caption in the Version of Record.
View the article online for updates and enhancements.
This content was downloaded from IP address 193.63.217.12 on 21/05/2020 at 12:54
  
Alanine dosimetry in strong magnetic fields: 
use as a transfer standard in MRI-guided 
radiotherapy 
Ilias Billas1,3, Hugo Bouchard2, Uwe Oelfke3, David Shipley1, Clare Gouldstone1 and Simon Duane1 
1National Physical Laboratory, Teddington, UK 
2Université de Montréal, Département de physique, Montréal, Canada 
3Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS 
Foundation Trust, London, UK 
Keywords: MRI-guided radiotherapy, magnetic field, reference dosimetry, Alanine 
1 ABSTRACT 
Reference dosimetry in the presence of a strong magnetic field is challenging. Ionisation chambers 
have shown to be strongly affected by magnetic fields. There is a need for robust and stable detectors 
in MRI-guided radiotherapy (MRIgRT). This study investigates the behaviour of the alanine dosimeter 
in magnetic fields and assess its suitability to act as a reference detector in MRIgRT. 
Alanine pellets were loaded in a waterproof holder, placed in an electromagnet and irradiated by 
60Co and 6 MV and 8 MV linac beams over a range of magnetic flux densities. Monte Carlo simulations 
were performed to calculate the absorbed dose, to water and to alanine, with and without magnetic 
fields. Combining measurements with simulations, the effect of magnetic fields on alanine response 
was quantified and a correction factor for the presence of magnetic fields on alanine was determined. 
This study finds that the response of alanine to ionising radiation is modified when the irradiation is 
in the presence of a magnetic field. The effect is energy independent and may increase the 
alanine/EPR signal by 0.2% at 0.35 T and 0.7% at 1.5 T. In alanine dosimetry for MRIgRT, this effect, if 
left uncorrected, would lead to an overestimate of dose. Accordingly, a correction factor, 𝑘𝑄𝐵 ,𝑄, is 
defined. Values are obtained for this correction as a function of magnetic flux density, with a standard 
uncertainty which depends on the magnetic field and is 0.6% or less. 
The strong magnetic field has a measurable effect on alanine dosimetry. For alanine which is used 
to measure absorbed dose to water in a strong magnetic field, but which has been calibrated in the 
absence of a magnetic field, a small correction to the reported dose is required. With the inclusion of 
this correction, alanine/EPR is a suitable reference dosimeter for measurements in MRIgRT. 
2 INTRODUCTION 
MRI-guided radiotherapy (MRIgRT), a state-of-the-art cancer treatment, is delivered by an MRI-linac 
which combines a linear accelerator (linac) with a Magnetic Resonance Imaging (MRI) scanner. An 
MRI-linac provides real-time images during a patient's treatment and greatly enhanced soft-tissue 
image contrast, while completely avoiding the radiation dose associated with treatment integrated 
imaging X-ray systems. MRIgRT is expected to facilitate real-time adaptive radiotherapy (RT) planned 
based on high contrast anatomical images, visualising anatomical changes of the patient, to explore 
the possibilities of an advanced personalised radiotherapy. 
A novel but known feature of this technology is that the external magnetic field affects the response 
of dosimeters and the dose distribution in medium. The lack of a standard for reference dosimetry of 
RT beams in magnetic field, motivates our investigation. 




































































Reference dosimetry for conventional radiotherapy is usually performed with ionisation chambers. 
In practice, secondary chambers are calibrated against a primary standard for absorbed dose to water 
(based on ionometry, water calorimetry, graphite calorimetry, etc.) and then used to calibrate the 
output of radiotherapy machines. In the presence of a magnetic field, the charged particles traversing 
the air-cavity of an ionisation chamber experience the additional Lorentz force induced by the 
magnetic field, which strongly modifies the chambers dose response and makes it challenging to 
perform beam output measurements in MRI-linacs. Recent works have shown that the uncertainty of 
ionisation chamber-based dosimetry is significantly increased by the presence of strong magnetic 
fields. Measurements and Monte Carlo (MC) calculations have previously been made to characterise 
the response of different type of ionisation chambers (Meijsing et al., 2009, Smit et al., 2013, O'Brien 
et al., 2016, Reynolds et al., 2013, Spindeldreier et al., 2017, Pojtinger et al., 2018). These works 
investigated the optimal chamber orientation with respect to magnetic field and radiation beam, 
parallel (||) or perpendicular (⊥), as well as the magnetic field correction factor at different flux 
densities. Considering the change of a Farmer-type chamber (mostly used as a reference detector) 
response in magnetic flux densities ranging from 0.35 T to 1.5 T relative to its response at 0 T, these 
studies found that when the long axis of the ionisation chamber is: 
• ⊥ to the magnetic field and the radiation beam is ⊥ to the magnetic field the changes range 
from 4% - 11.3%. 
• || to the magnetic field and the radiation beam is ⊥ to the magnetic field the change is ≤1%. 
• || or ⊥ to the magnetic field and the radiation beam is || to the magnetic field the change 
increases near to 2%. 
In the presence of the strong magnetic fields the radius of the circular motion of a charged particle 
vary with the mass density. The higher the mass density the higher the radius of the particle trajectory. 
Therefore, although the effect of the magnetic field is more pronounced in air cavities, it is also 
affecting the distribution of dose in water (Raaymakers et al., 2004, Raaijmakers et al., 2007, 
Raaijmakers et al., 2005, O'Brien et al., 2016). A study by O'Brien et al. (2016) characterised depth-
dose curves with an Elekta Unity MR-linac beam quality and showed that the presence of the magnetic 
field changes the absorbed dose at a reference depth by -0.5%. This effect needs to be taken into 
account and corrected for or it can be a part of the quality correction factor for the presence of 
magnetic field, 𝑘𝑄𝐵,𝑄, which has been discussed by O'Brien et al. (2016) and van Asselen et al. (2018) 
and is further described on section 3.2 of this paper. Both mentioned studies have used the analogy 
of radiation beam quality correction factor, which is defined as the ratio between the calibration 
coefficient in standard conditions and the calibration coefficient in user conditions, as stated on TRS 
398 (Andreo et al., 2000). In section 3.2, 𝑘𝑄𝐵 ,𝑄 is expressed as a product of the effect of the magnetic 
field on dose to water and on detector response. For different Farmer-type chambers, 𝑘𝑄𝐵,𝑄  ranges 
from 0.992 to 1.006 when the long axis of the chamber is parallel to magnetic field and 0.953 to 0.976 
when the long axis is directed perpendicular to magnetic field. 
Among other effects of ionisation chambers in magnetic fields, which increase the uncertainty on 
dose measurement, are the air gaps around the cavity (Hackett et al., 2016, Agnew et al., 2017). This 
will restrict the use of ionisation chambers in water phantoms to avoid a significant signal variation, 
i.e. 3.8% for a Farmer-type chamber (Agnew et al., 2017). It has been shown by Malkov and Rogers 
(2017), Spindeldreier et al. (2017) and Pojtinger et al. (2019) that dead volumes (or the true sensitive 
volume) should be taken into account when performing MC simulations. Small changes in the 
collecting volumes can lead to a deviation of 1.4% between the simulated and the experimentally 
determined dose response in magnetic fields (Pojtinger et al., 2019), on Farmer-type chambers. This, 





































































together with the intra-type chamber variation (i.e. non-radial symmetry), will result in significant 
disagreement with experimental data and will increase the uncertainty on tabulated MC calculated 
quality correction factors for the presence of magnetic field for specific chambers. 
Alanine is an α-amino acid with the chemical formula: CH3-CH(NH2)-COOH. When an alanine 
molecule is irradiated, it produces a stable free radical, CH3-C•H-COOH. The concentration of the 
stable free radicals can be measured as a signal (a dosimetric signal) using Electron Paramagnetic 
Resonance (EPR) spectroscopy and is proportional to the absorbed dose. A detailed description of 
alanine as a dosimeter has been given in the literature (McEwen and Ross, 2009, Malinen, 2014) and 
some primary points have been emphasised by McEwen M. et al. (2015). 
Alanine dosimeters provide an alternative to standard dosimetry systems, such as ionisation 
chambers. McEwen M. et al. (2015) has pinpointed the advantages of alanine dosimetry as a reference 
detector against an ionisation chamber in conventional radiotherapy. The National Physical 
Laboratory (NPL) provides an alanine reference dosimetry service (Sharpe et al., 1996, Sharpe and 
Sephton, 2000, Sharpe and Sephton, 2006), which can be used to measure therapy level absorbed 
dose in reference and non-reference conditions. Alanine has been used as a transfer standard for 
comparison of the absorbed dose measured from national standards laboratories in a Co-60 beam 
(Burns et al., 2011) and in megavoltage electron beams (McEwen M. et al., 2015) with a precision of 
0.1%. The use of alanine in dosimetry audits for megavoltage photons and electrons under standard 
conditions has been proven by Thomas et al. (2003) to be an essential detector to ensure national 
consistency in radiotherapy dosimetry. In non-standard conditions, such as small field beams 
(Massillon et al., 2013, Ramirez et al., 2011, Dimitriadis et al., 2017) and flattening filter free beams 
(Budgell et al., 2016) alanine has been used for absolute dosimetry measurements transfering 
traceability to a primary standard.  
Currently, the only primary standard that can provide traceability for reference dosimetry in 
magnetic field is the VSL’s water calorimeter (de Prez et al., 2019). To our knowledge, this is the only 
MRI-safe primary standard, which can also fit in the bore of the MRI scanner, that has performed 
direct measurements of absorbed dose to water in an Elekta Unity MR-linac and cross calibrated 
ionisation chambers to act as transfer standards. Nevertheless, as already explained above, the strong 
magnetic field modifies the response of air-filled ionisation chambers, and the correction 𝑘𝑄𝐵 ,𝑄 for 
this effect may significantly increase the uncertainty of reference dosimetry. On the other hand, 
alanine/EPR offers an alternative to ionisation chamber-based reference dosimetry, in which the 
magnitude of the electron return effect (ERE) may be reduced compared to the effect in an air-filled 
ionisation chamber. 
Taking into account a) the disadvantages of the ionisation chamber response in magnetic field, b) 
the need to find a traceable dosimeter which will allow for MR safety, robustness, stability and dose 
response and c) the wide use of alanine as a reference detector for standard and non-standard 
radiation beams, the aim of this work is to investigate the performance of alanine in the presence of 
strong magnetic field and to explore its suitability to act as a reference class detector for MRIgRT 
systems. 
The use of alanine as a transfer standard implies that it is used in the same conditions that it has 
been calibrated (primary condition). Where these conditions do not match the measurement 
conditions (i.e. alanine is irradiated in a different beam quality) a correction to account for changes in 
the response relative to those under calibration conditions need to be applied. For instance, the 
alanine/EPR signal depends on the energy spectrum of the radiation beam. Corrections for this effect 
have been well quantified in the literature (Bergstrand et al., 2005, Zeng et al., 2004, Sharpe, 2003, 





































































Bergstrand et al., 2003, Anton et al., 2013). When alanine is used to measure dose in the presence of 
a strong magnetic field (such as in MRI-linac systems), and an alanine calibration is available only in 
the absence of the magnetic field, then a correction factor that would account for the effect of the 
magnetic field needs to be applied. This factor will correct for both the effect of the magnetic field on 
dose to water and on alanine response. In the present study, we perform measurements and MC 
simulations to quantify the effect of the magnetic field on alanine response (described as alanine 
intrinsic sensitivity) and generate magnetic field correction factors for alanine. A statistical analysis, 
including an investigation of the effect of the air gaps associated with the alanine holder, is also 
presented. 
3 MATERIALS AND METHODS 
3.1 ALANINE DOSIMETRY 
Alanine pellets comprise of 90% L-α-alanine and 10% high melting point paraffin wax (m.p. 98 oC), 
by weight (Sharpe et al., 1996). Alanine is near water-equivalent, but not waterproof, with a density 
of about 1.2 g/cm3 and it has a linear response to dose. It also has good reproducibility (0.3% variation 
between individual dosimeter pellets) and a small energy dependence, less than 1% relative to a 60Co 
beam (Bergstrand et al., 2005, Zeng et al., 2004, Sharpe, 2003, Bergstrand et al., 2003, Anton et al., 
2013). EPR spectroscopy is used to detect and quantify the number of the stable free radicals that are 
created by the ionising radiation. The alanine/EPR signal is the corrected alanine peak-to-peak 
intensity per unit dosimeter mass, expressed in Gy to water, using a calibration curve derived from 
reading out alanine irradiated under reference conditions in 60Co. The corrections include effects such 
as temperature during irradiation and spectrometer sensitivity. If alanine is irradiated in some other 
conditions, then a correction may be needed to account for any change in the intrinsic sensitivity of 
alanine, which may be defined as the alanine/EPR signal per unit absorbed dose to alanine. 
3.2 ALANINE REFERENCE DOSIMETRY IN A MAGNETIC FIELD 
The reference measurement of absorbed dose to water, in the presence of a magnetic field B, 𝐷𝑤,𝑄𝐵 , 
using alanine, is given by: 
 𝐷𝑤,𝑄𝐵 = 𝑀𝑎𝑙,𝑄𝐵 ∙ 𝑁𝐷,𝑤,𝑄𝐵  (1) 
where, 𝑀𝑎𝑙,𝑄𝐵  and 𝑁𝐷,𝑤,𝑄𝐵  are the alanine/EPR signal and the calibration coefficient, respectively, of 
the alanine detector in the presence of magnetic field. The magnetic field affects the absorbed dose 
to water at the measurement point, 𝐷𝑤,𝑄, the absorbed dose to the alanine pellet, 𝐷𝑎𝑙,𝑄, and may also 





Note that this relation is analogous to the definition of detector dose response (or sensitivity) 
proposed by Bouchard and Seuntjens (2013). 
If the alanine calibration is only available for a beam quality 𝑄 in the absence of any magnetic field, 
𝑁𝐷,𝑤,𝑄, then a correction factor for the effect of the magnetic field is needed: 
 𝐷𝑤,𝑄𝐵 = 𝑀𝑎𝑙,𝑄𝐵 ∙ 𝑁𝐷,𝑤,𝑄 ∙ 𝑘𝑄𝐵,𝑄 (3) 




































































This correction factor is defined, by analogy with the usual quality dependent correction factor, 𝑘𝑄,𝑄0 














The absorbed dose to water, with magnetic field, 𝐷𝑤,𝑄𝐵 , and without magnetic field, 𝐷𝑤,𝑄 , was 
calculated by using MC simulations. The alanine/EPR signal at a quality 𝑄, 𝑀𝑎𝑙,𝑄, can be derived from 
equation (2) as the product of the absorbed dose to alanine at a quality 𝑄, 𝐷𝑎𝑙,𝑄, and the alanine 
intrinsic sensitivity at the same quality 𝑄, 𝑅𝑎𝑙,𝑄. The effect of the magnetic field on the alanine intrinsic 





This was determined by combining measurements of the alanine/EPR signal with the absorbed dose 








𝐷𝑤,𝑄𝐵 𝐷𝑤,𝑄 ∙⁄ 𝐷𝑎𝑙,𝑄 𝐷𝑎𝑙,𝑄𝐵⁄
𝑘𝑄𝐵 ,𝑄
 (6) 
3.3 EXPERIMENTAL SETUP 
Alanine pellets, of approximately 2.3 mm height and 5 mm diameter, were placed in a waterproof 
holder of Polyether Ether Ketone (PEEK) material shaped like a Farmer-type ionisation chamber, in an 
electromagnet (GMW 3474-140) and irradiated by either a 60Co source or conventional 6 MV and 8 MV 
Elekta Synergy linac beams. A disassembled view of the NPL alanine holder is shown in Figure 1. The 
external dimensions of this holder are designed to match a PTW/30013 Farmer chamber. The holder 
has internal dimensions of 5.2 mm diameter (tolerance of 0.2 mm to allow the loading and unloading 
of the pellets) and a length of 20.5 mm. The measurement reference point of the PTW/30013 Farmer-
type chamber is very close to the centre of the third pellet from the tip of the holder. Thus, the first 
five pellets from the tip of the holder were used for analysis. 
 
Figure 1: NPL alanine holder. 
In 60Co the alanine dosimeters were irradiated in an in-house poly-methyl methacrylate (PMMA) 
phantom, 2 cm x 5 cm x 26 cm, with a drilled insert to enable the alanine holder to fit in. Any air gap 
between the insert and the holder was carefully filled with water to avoid the ERE. The phantom was 
designed to fit in the 5 cm gap between the two poles of the magnet, which provide a maximum 









































































(measurement point) was 162 cm and alanine pellets were irradiated at a depth of 1 cm at five 
magnetic flux densities (0 T, 0.5 T, 1 T, 1.5 T and 2 T). 
In the Elekta Synergy linac setup, a water phantom, 7 cm x 18 cm x 19 cm, was designed to place the 
alanine holder between the 7 cm gap of the magnetic poles (Figure 2), which provide a maximum 
magnetic flux density of 1.6 T. An insert frame-holder was built to set up the alanine holder in the 
water tank and between the two poles of the magnet. The surface to source distance (SSD) was 
305 cm, with alanine irradiated at a water equivalent depth of 5 cm and magnetic flux densities of 0 
T, 0.35 T, 0.5 T, 1 T and 1.5 T. 
 
Figure 2: Front schematic view (cross-section) of the experimental setup. PMMA or water phantom fits between the two 
magnetic poles with a gap of either 5 cm or 7 cm that gives a maximum magnetic flux density of either 2 T or 1.6 T. Both 
magnetic field and radiation beam are orientated perpendicular to the long axis of the alanine holder. 
In both 60Co and Elekta Synergy linac radiation beams, the long axis of the alanine holder was 
positioned in a) the centre of the two magnetic poles, b) perpendicular orientation to the radiation 
beam, along z-axis and c) perpendicular orientation to the magnetic field, along the x-axis. The 
magnetic field uniformity in an area of 3 cm2 along the centre of the two magnetic poles (in z and y 
direction) was found to be within ±0.5 mT. The radiation field was collimated to fill the gap between 
the two magnetic poles. A calibrated thermistor was placed close to the holder to record the ambient 
temperature needed to correct the effect of the alanine signal due to temperature. 
The effect of the magnetic field on the photon beam symmetry of the linac was checked. A Sun 
Nuclear IC Profiler was set at 100 cm iso-centre (using the same gantry angle as the experimental 
setup) and irradiated with a 10 cm x 10 cm beam field. With a magnetic flux density of 0 T, initial beam 
steering adjustment was performed to give zero tilt using the IC Profiler. The 2T (crossline) and 2R 
(inline) error values, which indicate if there is any asymmetry of the beam, were set to zero. The 
magnetic flux density was set to 1.5 T and it was found that symmetry was different by 1.5% compared 
to profiles without magnetic field (crossline and Inline profiles with magnetic flux densities set at 0 T 
and 1.5 T are shown on  Figure 3). Beam steering was adjusted to eliminate the tilt (2T and 2R error 
values set back to zero) and the profile symmetry matched the beam without magnetic field. 
Therefore, it was concluded that zeroing the 2T and 2R error values was a good method to restore the 






































































































 Figure 3: Inline and crossline profiles with 1.5 T and without magnetic field of a 10 cm x 10 cm at 8 MV linac beam. 
Here, we must point out, that the magnetic flux density at the iso-centre was less than 0.05 mT, 
when the electromagnet was set up to give 1.5 T between the poles, and any effect on the IC profiler 
signal due to the magnetic field was found to be negligible. 
3.4 AIR GAPS ON THE FARMER COMPATIBLE ALANINE HOLDER 
Alanine is a solid-state detector and is expected not to have a similar strong effect on ERE as air filled 
ionisation chambers. However, air gaps exist inside the holder where the alanine pellets are located, 
and two cases of air gaps were identified and investigated: 
1. Bevel-air-gap: alanine pellets do not have a flat surface, but instead they form a bevelled edge 
(Figure 4), which introduces air gaps when loaded in the holder. This creates a maximum of 
0.052 cm air gap around the bevelled edge between the two pellets. The first (close to the tip) 
and the last (close to the stem) pellet form the half of this air gap (0.026 cm). 
2. Cylindrical-air-gap: the internal diameter of the holder has a tolerance of 0.02 cm to allow the 
pellets to be loaded and unloaded in the holder. This forms an air gap between the inner 
holder wall and the pellets of 0.01 cm (Figure 4). 
MC simulations were performed for both cases to investigate the effect of air gaps on the alanine 
signal. This effect must be included as a component in the measurement uncertainty, when alanine is 
used as a dosimeter in the presence of the magnetic field. This is further explained in section 4.8.2. In 
any case, any effect (including the fluence perturbation by the PEEK holder) will be part of the alanine 
magnetic field correction factor, explained in section 3.2. 






































































Figure 4: Alanine bevel-air-gap of 0.052 cm, formed due to the pellet’s bevelled edge, and cylindrical-air-gap of 0.01 cm, 
due to a slightly bigger internal dimeter of the holder compared to the external dimeter of the alanine pellet. 
3.5 MONTE CARLO SIMULATIONS 
MC simulations of detector response play a major and increasingly important role in accurate 
radiation dosimetry, including the characterisation of physical properties of beams and of radiation 
detectors. MC radiation transport codes, such as EGSnrc and PENELOPE have demonstrated a self-
consistency test, by performing a Fano cavity test on MV beams, at a level of 0.1%. It has also been 
shown that the level of agreement with ionisation chamber experimental data, being the most difficult 
challenge for such a technique, is of the order of 0.3%.  
In the presence of the magnetic field, studies (Bouchard et al., 2015, Bouchard and Bielajew, 2015, 
de Pooter et al., 2015) have demonstrated that is necessary to define special conditions under which 
the Fano cavity test can be performed to check the consistency of MC transport algorithms. One of 
the key transport parameters in EGSnrc that needs to be adjusted to ensure more accurate MC 
simulations in the presence of magnetic field, is EM ESTEPE. This parameter sets a value for an 
additional step size restriction based on magnetic field change and direction change for charged 
particle transport in an electromagnetic field. Research undertaken in the EMPIR project of MR-guided 
radiotherapy (EMPIR 15HLT08 MRgRT), has shown that the EM ESTEPE parameter needs to be 
reduced from its default value when the material density is low (i.e. for air the EM ESTEPE = 0.01) in 
order to achieve the desired level of internal consistency of around 0.1% with EGSnrc (MRgRT, 2019). 
In this study, MC simulations were performed to include calculations of absorbed dose to water and 
to alanine, the investigation on the effect of the air gaps around the alanine pellets and the uncertainty 
estimation due to the random position of the alanine pellets inside the holder.  
The usercode cavity that forms part of the EGSnrc code system (Kawrakow I et al., 2011) 
(development version: GitHub: Aug 2017) was used. An accurate model of the experimental setup 
consisting of the two magnetic poles, the bespoke water tank, the holder and the alanine pellets was 
first constructed. The dimensions and material specifications used were taken from the associated 
manuals, test certificates and in-house dimensional measurements. In the MC simulation, the pellet 
medium was set to be a 90:10 mixture of alanine and paraffin wax binder. The medium density was 
set to the measured pellet bulk density (1.23 g/cm3), and the alanine stopping power density effect 
correction was based on the crystalline density (1.42 g/cm3). Following Zeng et al. (2005) the 
alanine/EPR signal was replaced by dose to the pellet mixture since, over the relevant range of 














































































±0.15%. The effect of this approximation on the calculation of the dose to alanine ratio, with and 
without the magnetic field, is expected to be negligible.  
The cut-off energy for electrons (AE and ECUT) was set to 0.521 MeV and for photons (AP and PCUT) 
to 0.01 MeV. For the simulations of the external magnetic field, the default electromagnetic field 
macros (EMF_MACROS) were enabled, and EM ESTEPE was set to 0.01. All other parameters were set 
to their default values. 
Phase space data of the 6 MV and 8 MV Elekta Synergy x-ray beams were generated at 270 cm from 
the target, using the BEAMnrc usercode, for the purpose of the detector simulations. For beam 
validation at 0 T, depth dose and profile measurements were performed at 279 cm from the target. 
The radiation beam was collimated, at the machine isocentre, by 1.9 cm and 4.4 cm in the crossline 
and inline direction, respectively. A parallel plate chamber (NACP-02) was placed in a water tank for 
depth dose measurements, and profiles were measured by irradiating EBT-3 films with a 5 cm build-
up. Films were processed and analysed using a method developed by Bouchard et al. (2009). A model 
of a previously validated 60Co beam (Costa et al., 2018), which configures the same beam 
characteristics as in this study, was used for the MC simulations. 
The following three sections (3.5.1, 3.5.2, 3.5.3) will describe the MC simulations that were 
performed to support investigations in this study. 
3.5.1 Experimental setup model validation 
For the model validation of the experimental setup, including the electromagnet, alanine and holder, 
measurements were performed using the setup explained in section 3.3. In this case, measurement 
and MC simulations were performed with the holder partially loaded with alanine pellets, so that an 
air gap of nominal 0.44 cm occurs between the stem and the first pellet (Figure 5). In this air gap, the 
electrons follow on average a curved trajectory in accordance with the Lorentz force by increasing the 
dose on the first pellet, which are distributed along the long axis of the holder towards the tip. The 
magnetic flux density was 1.5 T and alanine pellets were irradiated with 6 MV and 8 MV delivering 20 
Gy in each case. In the simulations, the total dose per incident particle was scored in each pellet. 
Unfortunately, it was not possible to perform similar measurements to validate the experimental 
setup at 1.5 T in the 60Co beam during the study. Nevertheless, the characteristics of the 60Co beam 
model, used in this study, have been benchmarked by Costa et al. (2018). 
 
Figure 5: Alanine holder filled with pellets for the purpose of experimental setup validation. The direction of the magnetic 
field (pointing into the plane of the paper) and radition beam (lying in the plane of the paper) with respect to the holder are 
shown toghether with the affected electron trajectories. 












































































3.5.2 Monte Carlo model for the air gap effect 
MC simulations were performed to determine the effect of the air gaps around the alanine pellets. 
A model of the holder loaded with alanine pellets was used and three sets of simulations were 
performed: a) full model including both air gaps (bevel and cylindrical), b) full model with the air gaps 
created from the bevelled edge of the alanine pellets (bevel-air-gaps only) filled with alanine medium 
and c) full model with no air gaps (both air gaps filled with alanine medium). Figure 6 depicts the three 
models. Simulations were performed for all beam qualities at all examined magnetic flux densities. 
For each combination, the total dose per incident particle was scored to the first five pellets from the 
tip of the holder. Any effect of the magnetic field on the dose distribution in alanine medium was 
removed (for 1.5 T the dose was found to be negatively deviated by 0.03%, 0.3% and 0.4% from the 
dose at 0 T for 60Co, 6 MV and 8 MV, respectively). Thus, only the air gap effect is considered for the 
comparison. 
 
Figure 6: MC models for the investigation of the effect of the air gaps around the alanine pellets. 
3.5.3 Uncertainty due to the air gaps 
When alanine pellets are loaded inside the holder, they will not be located symmetrically but rather 
randomly due to the air gap of 0.02 cm (see section 3.4). Depending on the position of the air gaps 
inside the holder with respect to the magnetic field, the ERE will either increase or decrease the dose 
in each alanine pellet. Due to the unpredictable location of the pellets, it is difficult to calculate what 
the effect would be and correct for it. However, known air gaps of 0.02 cm, which is the maximum 
between the holder and the alanine pellets, can be modelled by MC simulations to estimate the effect 
and include it in the uncertainties (see section 4.8.2). For that purpose, a model of the holder loaded 
with nine alanine pellets was built and MC simulations were performed by shifting the pellets in the 
x- and z-axis as shown in Figure 7 (dimensions not to scale), allowing the maximum achievable air-gap 
(0.02 cm). The total dose per incident particle was scored to the first five pellets from the tip of the 
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Figure 7: MC models to evaluate uncertainties due to air gaps. (a) coordinates indicating the direction of magnetic field and 
radiation beam with respect to the alanine holder, (b) model of the centred alanine pellets in the holder and (c, d, e, f) offset 
alanine pellets along the short axis (x- and z-axis) creating an air gap of 0.02 cm. Dimensions not to scale. 
4 RESULTS 
4.1 VALIDATION OF THE BEAM MODELS 
The 6 MV and 8 MV beam models were validated by comparing the simulated with the experimental 
dose profiles and depth doses as shown in Figure 8. For each plot, the data were normalised to the 
integral of the curve to minimise the effect of point-to-point variations in film sensitivity. The MC 
profiles agree with the film measurements within the uncertainty of the single channel analysis made 
of the film data, which in this study was estimated to be 2%. 
(a) Coordinates
(d) Negative to x-axis (f) Positive to x-axis(e) Negative to z-axis





















































































Figure 8. Validation of the MC models by comparing experimental and simulated profiles and depth doses, at 1.5 T, for 6 
MV and 8 MV beam energies.  
4.2 ALANINE MODEL AND EXPERIMENTAL SET UP VALIDATION IN A MAGNETIC FIELD 
The validation of the experimental setup model for 6 MV and 8 MV with experiments was performed 
at a magnetic flux density of 1.5 T. It was found that the thickness of the air gap between the PEEK 
stem and the first alanine pellet, depends on the force that is applied to adjust the screw cap shown 
in Figure 1, which is used to secure the pellets inside the holder. Further measurements of five actual 
holders and pellets showed typical variations of the air gap in the order of 0.35 ± 0.02 cm, and so 
additional simulations with air gaps of 0.30 cm and 0.40 cm were made. Figure 9 shows the MC results 
(for three different air gaps) and the measurement results of the dose deposited at each alanine pellet, 
normalised to the average dose of all pellets, for 6 MV and 8 MV. The experimental data points for 
both energies agree with the MC calculated points of the two additional simulations, of 0.30 cm and 
0.40 cm air gaps, within the measurement uncertainties. The error bars on the experimental data 
represent the combined standard uncertainty of an alanine pellet (0.6%) and the uncertainty due to 
the air gaps as explained in section 4.8.2. The uncertainty on the MC data is in the order of 0.15%. For 
clarity, error bars are not included on the MC data. 





































































Figure 9. MC and measurement results, including air gaps of 0.30 cm, 0.40 cm and 0.44 cm (nominal air gap), of the dose 
deposited at each alanine pellet, normalised to the average dose of all pellets, for 6 MV and 8 MV, plotted against the 
distance measured from the front of the first alanine pellet. Note that the air gaps, on the x-axis of the two plots, are at the 
front face (0 cm). 
4.3 EFFECT OF AIR GAPS ON ALANINE IN A MAGNETIC FIELD 
Figure 10 shows the effect of the air gaps on the calculated dose-to-alanine for the three beam 
energies and all tested magnetic flux densities, based on the three sets of simulations described in 
section 3.5.2. Calculated data show how the dose to alanine changes when the air gaps created from 
the bevelled edge are simulated with alanine replacing the air, Figure 10 (a), and when both bevel and 
cylindrical air gaps are replaced with alanine medium, i.e. full model with no air gaps, Figure 10 (b). In 
both cases, data were normalised to the MC results of the full model (including both air gaps). In Figure 
10 (b), the maximum deviation from the full model was found to be 0.45% and 0.55% for 6 MV and 8 
MV, respectively, at 1.5 T. In Figure 10 (a), the maximum deviation was found to be at 1 T and 1.5 T 
and was less than 0.4% for both 6 MV and 8 MV. For the 60Co beam all data from both figures were 
found to be less than 0.4%. 
 
Figure 10: MC results of the effect of the air gaps on the calculated dose on alanine for 60Co, 6 MV and 8 MV at all tested 
magnetic flux densities, when the bevelled-air-gaps (a) and the annular-air-gap (b) are filled with alanine medium. Data are 
normalised to the MC results of full model. Error bars represent the combined MC uncertainties. 





































































4.4 EFFECT OF THE MAGNETIC FIELD ON ABSORBED DOSE TO WATER 
The effect of the magnetic field on absorbed dose to water at the measurement point, 𝐷𝑤,𝑄 , is 
needed to determine the alanine magnetic field quality correction factor and its relative intrinsic 
sensitivity, as explained in section 3.2. For that purpose, depth doses in water for each beam energy 
and at magnetic flux densities up to 3 T were calculated by using MC simulations. Figure 11 shows the 
MC calculated 𝐷𝑤,𝑄𝐵 𝐷𝑤,𝑄⁄  ratios as a function of magnetic flux density for the three beam energies. 
After 𝑑𝑚𝑎𝑥 , for all beam energies, depth doses in the presence of a magnetic field, although 
systematically lower compared to 0 T, were found to be similar. Therefore, the 𝐷𝑤,𝑄𝐵 𝐷𝑤,𝑄⁄  ratios at 
each magnetic flux density were determined from the average ratios after 𝑑𝑚𝑎𝑥, which results in a 
level of standard uncertainty of 0.04%. 
 
Figure 11: MC calculated 𝐷𝑤,𝑄𝐵 𝐷𝑤,𝑄⁄  ratios as a function of magnetic flux density for 
60Co, 6 MV and 8 MV. 
4.5 ALANINE RESPONSE IN A MAGNETIC FIELD 
Figure 12 summarises the alanine/EPR signal for measurements in a magnetic field, 𝑀𝑎𝑙,𝑄𝐵 , 
normalised to the signal at zero magnetic field, 𝑀𝑎𝑙,𝑄, as a function of magnetic flux density for the 
three beam energies. For each plot and each magnetic flux density, data represent measurements 
over three days and their distribution is displayed in a form of box plot. Note that crosses (x) on each 
box plot indicate the mean value of the normalised alanine signal for each magnetic flux density over 
three days. 
For zero magnetic field and for each energy, the pellet-to-pellet variation of the signal has a standard 
deviation of up to 0.52%. This results in a standard uncertainty of the mean of 0.13% or better, 
considering the number of the pellets used in this study. However, as the magnetic flux density is 
increased, for each energy, the standard deviation also increases, up to 0.85% (standard uncertainty 
of the mean of 0.22%). 








































































Figure 12: Box plots presenting the ratio between the alanine/EPR signal for alanine measurements in a magnetic field, 
𝑀𝑎𝑙,𝑄𝐵, and without magnetic field, 𝑀𝑎𝑙,𝑄, for 
60Co, 6 MV and 8 MV. Data at each energy and each magnetic flux density 
represent measurements over three days. Crosses (x) show the mean value of the normalised alanine signal for each 
magnetic flux density over three days. 
4.6 QUALITY CORRECTION FACTOR FOR THE PRESENCE OF A MAGNETIC FIELD ON ALANINE 
The alanine quality correction factor as a function of a magnetic flux density is shown in Figure 13 
and Table 1, for the three beam energies. The error bars denote the overall combined standard 
uncertainty (ranging from 0.2% to 0.6%), as quoted in section 4.8, and include the effects of 
measurement repeatability, air gaps, linac drift and MC uncertainties. Figure 13 shows how the 
correction factor for each energy decreases with increasing magnetic flux density. Except for the data 
point at 0.5 T (1.0014) for 8 MV, all the remaining data points lie below unity, ranging from 0.9933 to 
0.9998 with an average of 0.9967 ±0.0027. Note that this correction includes both the effect of the 
magnetic field on absorbed dose to water and its effect on alanine intrinsic sensitivity. The latter effect 
is isolated in the following. 






































































Figure 13: Alanine quality correction factor for the presence of magnetic field, 𝑘𝑄𝐵,𝑄, for all examined magnetic flux 
densities for 60Co, 6 MV and 8 MV. The error bars denote the standard combined uncertainties estimated in section 4.8. 
Table 1: Alanine quality correction factor for the presence of a magnetic field, 𝑘𝑄𝐵,𝑄, for all examined 
magnetic flux densities for the three beam energies. Standard uncertainties estimated in section 4.8. 
Magnetic flux density (T) 60Co 6 MV 8 MV 
0.35 - 0.9992 ± 0.0026 0.9976 ± 0.0027 
0.50 0.9974 ± 0.0024 0.9984 ± 0.0027 1.0014 ± 0.0026 
1.00 0.9940 ± 0.0027 0.9954 ± 0.0040 0.9998 ± 0.0034 
1.50 0.9939 ± 0.0034 0.9964 ± 0.0060 0.9938 ± 0.0055 
2.00 0.9933 ± 0.0039 - - 
4.7 THE EFFECT OF THE MAGNETIC FIELD ON ALANINE RESPONSE 
The magnetic field effect on alanine intrinsic sensitivity may be represented by the quantity 𝐹𝑄𝐵 ,𝑄, 
relative intrinsic sensitivity, which is defined as the ratio of the alanine intrinsic sensitivity with and 
without magnetic field (equations (5) and (6) in section 3.2). This was obtained by combining 
measurements with MC simulations and is shown in Figure 15 and Table 2, for the three beam 
energies. The alanine over-response tends to increase with magnetic flux density, up to 1.0099 at 
8 MV in 1.5 T, but without any obvious trend as a function of energy. 







































































Figure 14: Alanine relative intrinsic sensitivity, 𝐹𝑄𝐵,𝑄, for all examined magnetic flux densities for 
60Co, 6 MV and 8 MV. The 
error bars denote the standard combined uncertainties estimated in section 4.8. 
Table 2: Alanine relative intrinsic sensitivity, 𝐹𝑄𝐵,𝑄, for all examined magnetic flux densities for the three 
beam energies. Standard uncertainties estimated on section 4.8. 
Magnetic flux density (T) 60Co 6 MV 8 MV 
0.35 - 1.0011 ± 0.0030 1.0038 ± 0.0030 
0.50 1.0035 ± 0.0027 1.0030 ± 0.0031 1.0006 ± 0.0030 
1.00 1.0079 ± 0.0030 1.0082 ± 0.0042 1.0057 ± 0.0036 
1.50 1.0051 ± 0.0037 1.0067 ± 0.0061 1.0099 ± 0.0056 
2.00 1.0050 ± 0.0042 - - 
4.8 UNCERTAINTIES 
The analysis of uncertainty here follows the Joint Committee for Guides in Metrology (JCGM) Guide 
to the Expression of Uncertainty in Measurement (JCGM, 2008). Uncertainties evaluated by statistical 
analysis are grouped as type A and the rest are grouped as type B. These are added in quadrature to 
give a combined standard uncertainty with coverage factor k = 1. 
The quoted relative standard uncertainties are shown in Table 3Error! Reference source not found.. 
This includes the overall combined relative standard uncertainties in 𝑘𝑄𝐵 ,𝑄 at 0.35 T and 1.5 T for 6 
MV and 8 MV. For 60Co, uncertainties are presented at 0.5 T and 1.5 T. For the rest of the magnetic 
flux densities at all three energy beams, the relative standard uncertainties are between the stated 











































































Table 3: Uncertainty budget for the determination of the quality correction factor for the presence of magnetic field on alanine, 𝑘𝑄𝐵,𝑄. 
 Relative standard uncertainty (%) 
60Co  6 MV  8 MV 
Uncertainty component  Type  0.5 T  1.5 T  0.35 T  1.5 T  0.35 T  1.5 T 
Measurement repeatability  A  0.06 0.22  0.06 0.20  0.08 0.11 
Air gaps  B  0.11  0.29  0.13  0.52  0.19  0.47 
Linac output correction  A  -  -  0.07  0.07  0.10  0.10 
Monte Carlo  A+B  0.15  0.15  0.15  0.15  0.15  0.15 
Overall combined relative 






0.39  0.22 
 
0.58  0.27 
 
0.52 
4.8.1 Measurement uncertainty and repeatability 
The uncertainty on the repeatability of the measurements is evaluated by considering the behaviour 
of the averaged signal over the alanine pellets at each magnetic flux density for each energy, over all 
experiments. The standard deviation of the mean was found to be ranging from 0.05% to 0.22%. 
4.8.2 Uncertainty due to air gaps 
Uncertainties due to the unknown spatial distribution of the alanine pellets in the PEEK holder were 
estimated using MC simulations as explained in section 3.5.3. Figure 15 (a) shows the MC calculated 
dose to alanine for each energy, when pellets are shifted in the x- and z-axis inside the alanine holder 
(see Figure 6). For clarity, Figure 15 (a), only includes data for 1.5 T, which are normalised with respect 
to when the pellets are centrally-located in the holder. This figure shows how the ERE is varying the 
dose to alanine at the different positions. The type A uncertainties were based on the root mean 
square (RMS) error of the four different distributions of the alanine pellets inside the holder. The 
uncertainties, for each energy, were found to increase with magnetic flux density up to 0.52% and 
0.47% for 6 MV and 8 MV at 1.5 T, respectively. For 60Co it was 0.52% at 2 T. For the other magnetic 
flux densities and for all beam energies the determined uncertainties were below 0.30%. The rise in 
uncertainties as a function of magnetic flux density is reflected by the length of the error bars in Figure 
15 (b), (c) and (d). These figures show the average normalised dose over the four shifted alanine 
positions, as per Figure 15 (a), for each energy beam at all examined magnetic flux densities. It can be 
observed that the error bars, at each energy beam, increases with magnetic flux density. The 
uncertainty due to the air gaps is the dominant component in the uncertainty budget and is applicable 
to the absorbed dose to water measured with the alanine detector, in the presence of a magnetic field 
using the holder designed for this study. 






































































Figure 15: MC simulations to investigate the uncertainty estimation due to the random position of the alanine pellets inside 
the PEEK holder. The MC calculated dose to alanine for all examined magnetic flux densities, when pellets are shifted in four 
different positions, with respect to the x- and z-axis inside the alanine holder, are shown for 60Co, 6 MV and 8 MV at 1.5 T 
(a). All data are normalised with respect to when the pellets are centrally-located in the holder. The average normalised 
dose over the four shifted positions, at the examined magnetic flux densities, are shown for 60Co (b), 6 MV (c) and 8 MV (d). 
4.8.3 Uncertainty due to linac output 
The short term (over one day) behaviour of the output from the Elekta Synergy linac beams was 
investigated during the alanine irradiation. The output was measured several times in-between the 
alanine irradiations using an ionisation chamber with the same experimental set up and always at 0 T. 
For each day of irradiation, the output (dose rate) was found to diverge by an average of -0.07% per 
hour. This deviation was considered, and used to correct the alanine signal, based on a linear fit 
between the ionisation chamber signal and the time. The uncertainty was estimated from the gradient 
of the residuals of the fit (RMS error) and estimated to be less than 0.1%, on average. 
4.8.4 Monte Carlo uncertainties 
In the MC simulations, the Type A uncertainties in the determination of the absorbed dose to water, 
and of the absorbed dose to alanine, with and without magnetic field, were typically 0.1%. For self-
consistency and transport parameters we estimated a Type B uncertainty of 0.1% (Kawrakow, 2000, 
Malkov and Rogers, 2016). The combined standard uncertainty on the MC simulations resulted in 
0.15%. 






































































The performance of the alanine dosimeter in the presence of a magnetic field has been investigated 
at three different photon beam energies over a range of magnetic flux densities. Alanine pellets were 
placed in a waterproof PEEK holder, developed in-house and shaped to match a Farmer-type chamber, 
in an electromagnet and irradiated by either a 60Co source or conventional 6 MV and 8 MV Elekta 
Synergy linac beams. The long axis of the alanine holder was positioned in the centre of the magnetic 
poles of the electromagnet and in perpendicular orientation relative to both radiation beam and the 
magnetic field. 
5.1 MC SIMULATIONS AND AIR GAP EFFECTS 
MC simulations were performed to: a) investigate the effect of the air gaps on dose to alanine (found 
around the pellets when  loaded in the PEEK holder), b) investigate the uncertainty due to the random 
position of the pellets inside the holder and c) calculate the absorbed dose to water and absorbed 
dose to alanine at the three beam qualities, with and without magnetic field, for the determination of 
the quality correction factor for the presence of magnetic field on alanine. 
The linac 6 MV and 8 MV photon beam MC models were validated by comparing simulated with 
experimental beam profiles and depth doses. For both energies a very good agreement was found 
between the simulations and the measurements. In validating the MC simulations of the experimental 
set up, for both energies at 1.5 T, the holder was loaded with alanine pellets, creating an air gap 
between the holder’s stem and the first pellet. It became apparent that the thickness of the air gap 
varies with respect to the force that is applied on the screw cap (Figure 1) to secure the pellets in the 
holder. Thus, MC simulations were performed for different air gaps and it was demonstrated that at 
least two of the MC models reproduced well the deviated behaviour of the dose along the pellets 
towards the tip of the holder. 
The results of the MC simulations show that the air gaps affect the alanine response, due to the ERE 
caused by the magnetic field, by as much as 0.45% and 0.55% for 6 MV and 8 MV, respectively, and 
less than 0.40% for 60Co over all the magnetic flux densities. The air gaps around other dosimeters, 
such as ionisation chambers, will increase the variation on the dose measurement, which can be as 
much as 3.8% for a Farmer-type chamber (Agnew et al., 2017). This can be eliminated by immersing 
the dosimeters in water (if waterproof). Alanine, however, is not waterproof and needs to be placed 
in a watertight holder for dose measurements in water. Due to the structure of the alanine pellets 
(they form bevelled edges) and the possible asymmetry in the positions of them inside the holder, it 
is difficult to avoid the effect caused by the existing air gaps. However, we can include this effect as a 
component in the measurement uncertainty, which increases with magnetic flux density and reaches 
0.52% for 6 MV and 0.47% for 8 MV at 1.5 T. For 60Co the highest uncertainty was 0.52% at 2 T (0.29% 
at 1.5 T). 
The maximum pellet-to-pellet variation of the measured alanine EPR/signal at 0 T, based on the 
number of the pellets considered in this study for the three energies, was found to be 0.52%, which 
results in a standard uncertainty of the mean of 0.13% or less. This is in line with previous studies 
(McEwen M. et al., 2015, Sharpe and Sephton, 2006, Anton, 2006), which investigated alanine 
dosimetry at therapy level energy beams. Nevertheless, for each energy, the variation was found to 
increase with the magnetic flux density up to 0.85%, reaching a standard uncertainty of the mean of 
0.22% at 1.5 T. The increase in variation is mainly attributable to the air gaps, which vary in size, based 
on the random locations of the pellets inside the holder. In this case, the ERE will diverge the alanine 
EPR/signal, as the path length of the secondary electrons will follow a curved trajectory due to the 
Lorentz force. These affected electrons will either deposit their energy to alanine or will curve back 
‘exiting’ the holder. 





































































5.2 QUALITY CORRECTION FACTOR FOR THE PRESENCE OF A MAGNETIC FIELD ON ALANINE 
The alanine quality correction factor for the presence of a magnetic field was determined by 
combining measurements of the alanine/EPR signal with calculations of the absorbed dose, to water 
and to alanine, in the presence of a magnetic field, by MC simulations. Figure 13 shows that the 
correction factor tends to decrease with increasing magnetic flux density. For each energy the 
correction, averaged over all non-zero magnetic flux densities, is 0.9946 ± 0.0019 for 60Co, 0.9973 ± 
0.0018 for 6 MV and 0.9982 ± 0.0033 for 8 MV. Although the change in the average correction factor 
with energy is monotonic, the uncertainties are too large to allow a more precise conclusion regarding 
energy dependence. The overall correction factor, 𝑘𝑄𝐵 ,𝑄 , takes account of all the effects of the 
magnetic field, on dose to water, dose to alanine, alanine sensitivity, and the fluence perturbation by 
the PEEK holder and by the air gaps. These effects are built in the 𝑘𝑄𝐵,𝑄, which can be used to correct 
the dose to water measured with alanine in the presence of a magnetic field, when alanine is 
calibrated in the absence of a magnetic field. If a different holder was used (holder material, air gap 
details, etc.), it would be necessary to recalculate the 𝑘𝑄𝐵,𝑄 correction factor. This correction factor is 
holder-dependent. 
5.3 THE EFFECT OF THE MAGNETIC FIELD ON ALANINE RESPONSE 
The effect on the alanine intrinsic sensitivity due to the magnetic field, 𝐹𝑄𝐵 ,𝑄, can be calculated by 
using the experimental data and the MC simulations as defined in equation (6). The intrinsic sensitivity 
describes the yield of stable free radicals per unit dose to alanine. It can be seen from Figure 14, that 
the alanine intrinsic sensitivity increases with magnetic flux density for all examined beam energies, 
without any obvious energy dependence. All 𝐹𝑄𝐵,𝑄  values lie above unity with the highest being 
1.0099 ± 0.0056 at 8 MV and at 1.5 T. A common linear fit 𝐹𝑄𝐵,𝑄~(1 + 𝑎𝐵) was made to the data, for 
all energies, and this indicates that the effect of a magnetic field on alanine is to increase its relative 
intrinsic sensitivity by 𝑎 = 0.0047 ± 0.0005 per T. This value, 𝑎, may be used to estimate the required 
correction factor, 𝑘𝑄𝐵,𝑄, for different flux densities, 𝐵, by combining the fit value of 𝐹𝑄𝐵 ,𝑄 with MC 
simulations of absorbed dose, to water and to alanine. 
6 CONCLUSION 
This study successfully characterised the performance of alanine irradiated in the presence of a 
magnetic field. It was found that the effect of the magnetic field on an alanine/EPR signal is energy 
independent and may be increased by 0.2% at 0.35 T and 0.7% at 1.5 T. Neglecting this effect, may 
introduce systematic errors in the measured absorbed dose to water in commercially available MRI 
linacs. Therefore, if alanine is calibrated in the absence of any magnetic field, a correction factor, 
𝑘𝑄𝐵 ,𝑄, needs to be applied for the determination of the true absorbed dose to water in the presence 
of a magnetic field. This correction factor, which depends on the geometry and material of the alanine 
holder, varies with magnetic flux density. Not applying this correction factor would results in an 
overestimation of the dose to water. With the inclusion of 𝑘𝑄𝐵,𝑄, alanine as an MR safe, robust and 
stable dosimeter with comparable uncertainties to a Farmer-type chamber, is a suitable dosimeter to 
act as a reference class detector for MRI-guided radiotherapy. 
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